Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy

NACompletedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

June 3, 2024

Study Completion Date

September 24, 2024

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

MRI and MRI-guided prostate biopsy

Multiparametric MRI prostates in the MRI arm will be performed using 1.5 or 3.0 Tesla scanner with a pelvic phased array coil and contrast injection. T2-weighted, diffusion weighted and dynamic contrast enhanced scans will be included and the reporting of MRI finding will be done according to PI-RADS (Prostate Imaging-Reporting and Data Systems) v2.1 recommendations. MRI-guided targeted biopsy will be performed by Urologists experienced in MRI-guided biopsy for men with PI-RADS score 3-5.

DIAGNOSTIC_TEST

TP-arm Systematic biopsy

Transperineal 24-core biopsy using a free-hand technique under local anaesthesia will be performed under transrectal ultrasound guidance for men in this arm

Trial Locations (8)

Unknown

Kwong Wah Hospital, Hong Kong

North District Hospital, Hong Kong

Pamela Youde Nethersole Eastern Hospital, Hong Kong

Prince of Wales Hospital, Hong Kong

Princess Margaret Hospital, Hong Kong

Queen Elizabeth Hospital, Hong Kong

Queen Mary Hospital, The University of Hong Kong, Hong Kong

United Christian Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER